Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid-Reference-Cited by-同舟云学术

Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid

Published:2017-10-06 Issue:1 Volume:32 Page:7-15
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Caobelli Federico^ORCID, ,Chiaravalloti Agostino,Evangelista Laura,Saladini Giorgio,Schillaci Orazio,Vadrucci Manuela,Scalorbi Federica,Donner Davide,Alongi Pierpaolo

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s12149-017-1213-0/fulltext.html

Reference24 articles.

1. Pacini F, Castagna MG, Cipri C, Schlumberger M. Medullary thyroid carcinoma. Clin Oncol. 2010;22:475–85.

2. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139–48.

3. Pellegriti G, Leboulleux S, Baudin E, Bellon N, Scollo C, Travagli JP, Schlumberger M. Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer. 2003;88:1537–42.

4. Marzola MC, Pelizzo MR, Ferdeghini M, Toniato A, Massaro A, Ambrosini V, et al. Dual PET/CT with (18)F-DOPA and (18)F FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: comparison with conventional imaging. Eur J Surg Oncol. 2010;36:414–21.

5. Kauhanen S, Schalin-Jantti C, Seppanen M, Kajander S, Virtanen S, Schildt J, et al. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer. J Nucl Med. 2011;52:1855–63.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [¹⁸F]F-DOPA PET/CT May Be Useful in Diagnostic and Prognostic Evaluation of Recurrent MTC;Clinical Thyroidology®;2024-08-01

2. 18F-DOPA;Radiopharmaceuticals;2024

3. Tumoren der Schilddrüse und Nebenschilddrüsen;PET/CT-Atlas;2024

4. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities;Reviews in Endocrine and Metabolic Disorders;2023-09-16

5. PET/CT with various radiopharmaceuticals in the complex diagnosis of medullary thyroid carcinoma: a review;Diagnostic radiology and radiotherapy;2023-07-05